Article
Leukemic potential of doubly mutant Nf1 and Wv hematopoietic cells.
Blood - 1 Mar 2003
Ingram David A, Wenning Mary Jo, Shannon Kevin, Clapp D Wade
Abstract excerpt
The development of molecularly targeted treatments of adult leukemias warrants investigation of these targets in similar pediatric leukemias. The NF1 tumor suppressor gene, which encodes a GTPase activating protein for p21(ras), is frequently inactivated in juvenile myelomonocytic leukemia (JMML). Other patients with JMML acquire activating RAS gene mutations. Recipient mice reconstituted with Nf1-/- fetal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
